[1] WU B, WU FB, XU T.Effectiveness and safety of indapamide versus CCBs for hypertension: a systematic review[J]. Chinese Journal of Evidence-Based Medicine(中国循证医学杂志), 2014(1): 34-43. [2] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China,Volume I(中华人民共和国药典一部)[M]. Beijing: China Medical Science Press, 2020. [3] Food and Drug Administration. Technical guidelines for dissolution test of oral solid preparations[M]. America: Food and Drug Administration, 1997. [4] Ministry of Health Labor and Welfare. Orange Book 2021[M]. Japan: Ministry of Health Labor and Welfare,2021. [5] ZHANG N.Considerations of the dissolution test for oral solid dosage forms[J]. Chin New Drugs J(中国新药杂志), 2013, 22(22): 2607-2610. [6] XIE MF.Improve the dissolution evaluation method and improve the level of solid drug preparations[J]. Chinese Journal of Pharmaceuticals(中国医药工业杂志), 2005, 36(7): 447-451. [7] XIE MF.The introduc about the Project of Drug Quality’s Re-evaluation in Japan(Series One of the Dissolution Study)[J]. Drug Standards of China(中国药品标准), 2005, 6(6): 42-46. [8] ZHANG X, SONG JC, CHEN L.Consistency evaluation of dissolubility of indapamide tablets between generic and original preparation[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2016, 13(7): 403-407. [9] ZHAO ZH, ZHAO ZJ, HAN RR, et al.Preparation and release in vitro of indapamide colon-specific microspheres[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2015, 35(23): 2118-2122. [10] LUO XR, XU J, FAN X, et al.Sampling results and assessment the quality of indapamide released preparation[J]. Chinese Journal of Drug Evaluation(中国药物评价), 2017, 34(4): 297-299. [11] LIU JJ, WANG Q, LI W, et al.Preparation of indapamide sustained-release tablets and release evaluation in vitro[J]. Journal of Harbin University of Commerce(哈尔滨商业大学学报), 2017, 33(2): 145-148. [12] XIE MF.Improve the evaluation method of dissolution and advance the level of pharmaceutical preparations-How to advance the internal-quality of the local oral preparation(series two of the dissolution study)[J]. Drug Standards of China(中国药品标准), 2006, 7(1): 48-51. [13] ZHANG JL, LI Y, CHEN T,et al.Establishment of a bio-relevance dissolution method for lansoprazole enteric capsules[J].Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(7): 702-707. [14] British Pharmacopoeia Commission.British Pharmacopoeia 2021[M]. England: The Stationery Office, 2021. [15] The United States Pharmacopeial Convention. U.S.Pharmacopeiay 43[M]. America: The United States Pharmacopeial Convention, 2019. [16] Ministry of Health Labor and Welfare. The Japanese Pharmacopoeia 18[M]. Japan: Ministry of Health Labor and Welfare, 2021. [17] YU SS, ZHANG ZF, LI ZQ.Investigation and countermeasures to the current status of the generics quality consistency evaluation[J]. The Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2015, 20(1): 118-120. |